Predictors of Human Papillomavirus (HPV) Vaccine Acceptability Among Physicians, Their Knowledge on Cervical Cancer, and Factors Influencing Their Decision to Recommend It
Bandar Alosaimi,Deema Fallatah,Samar Abd ElHafeez,Marina Saleeb,Huda Alshanbari,Maaweya Awadalla,Mamoun Ahram,Mohammad Khalil
DOI: https://doi.org/10.2147/jmdh.s484534
2024-11-17
Journal of Multidisciplinary Healthcare
Abstract:Bandar Alosaimi, 1 Deema I Fallatah, 2 Samar Abd ElHafeez, 3 Marina Saleeb, 4 Huda M Alshanbari, 5 Maaweya Awadalla, 1 Mamoun Ahram, 6 Mohammad Adnan Khalil 7 1 Research Center, King Fahad Medical City, Riyadh Second Health Cluster, Riyadh, Saudi Arabia; 2 Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia; 3 Epidemiology Department, High Institute of Public Health, Alexandria University, Alexandria, Egypt; 4 MARS Global, Covent Garden, London, UK; 5 Department of Mathematical Sciences, College of Science, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia; 6 Department of Physiology and Biochemistry, School of Medicine, The University of Jordan, Amman, Jordan; 7 Department of Basic Medical Sciences, Faculty of Medicine, Aqaba Medical Sciences University, Aqaba, Jordan Correspondence: Bandar Alosaimi; Mohammad Adnan Khalil, Email ; Introduction: In Saudi Arabia, the HPV vaccine is administered to young females through school-based immunization programs; however, the program's efficacy depends on parental consent, with physicians acting as primary determinants in parental decision-making regarding HPV vaccination. Methods: In this cross-sectional study, we recruited 128 physicians and assessed their knowledge and attitudes toward cervical cancer, HPV, and the HPV vaccine, and unraveled predictors of HPV vaccine acceptability and factors that would influence recommending the vaccine. Results: Although the major factor that influenced recommending the vaccine negatively was the fear of vaccine side effects, a positive influence of the physician's personal reading (91%), recommendations from colleagues (88%), and government directives (87%) provided reassurance and increased confidence in recommending the vaccine. Longer clinical experience and institutional awareness were found to be a predictors of favorable recommendation of HPV vaccination. Physicians in vaccine-related medical specialty with more than 4 years of experience were 5 to 6 times more likely to have positive attitude and better knowledge regarding HPV and HPV vaccination. A notable finding was that participants who reported knowing a woman suffering from cervical cancer had more positive attitudes compared to those who did not. Discussion: This study identified physicians' personal reading, peer recommendations, and government directives as factors affecting the physicians' decision to recommend HPV vaccine, and found that longer clinical experience and institutional awareness were predictors influencing physicians to recommend the vaccine. It also emphasizes on the influence of healthcare providers in promoting the HPV vaccination and the need for designing interventions targeting specific demographic and professional groups that would be more effective in improving better knowledge and promoting positive attitudes towards these critical public health issues. Keywords: HPV vaccine, cervical cancer, human papillomavirus, factors, physicians, knowledge, attitudes Human papillomavirus (HPV) is a family of closely related, non-enveloped double-stranded DNA viruses, with over 200 varieties, including types 6, 11, 16, and 18. The most common infection is of the genital tract. 1 High-risk HPV types 16 and 18 are oncogenic variants that precipitate more than 99% of Cervical Cancer cases (CC) worldwide. 2 CC is one of the most prevalent gynecological malignancies, and the fourth most common cancer type in women worldwide, following breast, colorectal and lung cancers, with over 662,000 new cases and more than 348,000 related deaths annually. 3 In 2018, the World Health Organization (WHO) issued a call for immediate action to eradicate cervical cancer. Although the prevalence of HPV in Saudi Arabia is relatively low compared to the global average of 11–12%, and cervical cancer represents approximately 2.6% of all cancers in women in the country, the mortality rate associated with cervical cancer remains a significant concern. 4–6 This is particularly worrying given that many cases are diagnosed at advanced stages, primarily due to inadequate screening coverage and limited public awareness of the disease. CC is a preventable and curable disease, primarily by prevention, early diagnosis, application of various screening methods, and treatment measures. 7 Currently, there are three vaccines designed to prevent cervical cancer by targeting high-risk types of human papillomavirus (HPV), particularly HPV-16 and HPV-18, which are responsible for the majority of cervical can -Abstract Truncated-
health care sciences & services